Peripheral blood DNA methylation detected in the BRCA1 or BRCA2 promoter for sporadic ovarian cancer patients and controls

Clinica Chimica Acta

Volumn 412, Issue 15-16, 2011, Pages 1472-1475

  Bosviel, Rémy ^a   Michard, Emilie ^a   Lavediaux, Guillaume ^a   Kwiatkowski, Fabrice ^a   Bignon, Yves Jean ^b   Bernard Gallon, Dominique J ^c  

^a CENTRE JEAN PERRIN   (France)

^b CRNH AUVERGNE   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

BRCA1; BRCA2; DNA methylation; QAMA; Sporadic ovarian carcinoma

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ARTICLE; BLOOD CELL; CANCER GENETICS; CANCER PATIENT; CONTROLLED STUDY; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; FEMALE; FRANCE; GENE MUTATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BRCA1 PROTEIN; BRCA2 PROTEIN; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; RISK FACTORS; YOUNG ADULT;

EID: 79956318734     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.04.027     Document Type: Article

References (17)

1. Ozols R.F., Bookman M.A., Connolly D.C., et al. Focus on epithelial ovarian cancer. Cancer Cell 2004, 5:19-24.
2. Fojo T., Bates S. Strategies for reversing drug resistance. Oncogene 2003, 22:7512-7523.
3. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
4. Konstantinopoulos P.A., Fountzilas E., Pillay K., et al. Carboplatin-induced gene expression changes in vitro are prognostic of survival in epithelial ovarian cancer. BMC Med. Genomics 2008, 1:59.
5. Vardi A., Bosviel R., Rabiau N., et al. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells. 2010, 24:393-400.
6. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:9821-9826.
7. Eads C.A., Danenberg K.D., Kawakami K., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 2000, 28:E32.
8. Zeschnigk M., Bohringer S., Price E.A., Onadim Z., Masshofer L., Lohmann D.R. A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus. Nucleic Acids Res. 2004, 32:e125.
9. Frommer M., McDonald L.E., Millar D.S., et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1827-1831.
10. Catteau A., Harris W.H., Xu C.F., Solomon E. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 1999, 18:1957-1965.
11. Chan K.Y., Ozcelik H., Cheung A.N., Ngan H.Y., Khoo U.S. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res. 2002, 62:4151-4156.
12. Teodoridis J.M., Hall J., Marsh S., et al. CpG island methylation of DNA damage response genes in advanced ovarian cancer. Cancer Res. 2005, 65:8961-8967.
13. Wang Y.Q., Zhang J.R., Li S.D., et al. Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway. Cancer Sci. 2010, 101:1618-1623.
14. Collins N., Wooster R., Stratton M.R. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br. J. Cancer 1997, 76:1150-1156.
15. Gras E., Cortes J., Diez O., et al. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors. Cancer 2001, 92:787-795.
16. Dhillon V.S., Shahid M., Husain S.A. CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in granulosa cell tumors (GCTs) of ovarian origin. Mol. Cancer 2004, 3:33.
17. Catteau A., Morris J.R. BRCA1 methylation: a significant role in tumour development?. Semin. Cancer Biol. 2002, 12:359-371.